The pathogenesis of rheumatoid arthritis: new insights from old clinical data?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pathogenesis of rheumatoid arthritis: new insights from old clinical data?
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 8, Issue 4, Pages 235-243
Publisher
Springer Nature
Online
2012-03-13
DOI
10.1038/nrrheum.2012.23
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of Proteoglycan-Induced Arthritis by Anti-CD20 B Cell Depletion Therapy Is Mediated by Reduction in Autoantibodies and CD4+ T Cell Reactivity
- (2014) K. Hamel et al. JOURNAL OF IMMUNOLOGY
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression
- (2011) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- The effects of golimumab on radiographic progression in rheumatoid arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy
- (2011) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice
- (2011) Stephan Blüml et al. ARTHRITIS AND RHEUMATISM
- Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity
- (2011) Xin Chen et al. FEBS LETTERS
- CTLA-4-Ig Therapy Diminishes the Frequency but Enhances the Function of Treg Cells in Patients with Rheumatoid Arthritis
- (2011) Crisol Álvarez-Quiroga et al. JOURNAL OF CLINICAL IMMUNOLOGY
- B Cell Depletion Enhances T Regulatory Cell Activity Essential in the Suppression of Arthritis
- (2011) K. M. Hamel et al. JOURNAL OF IMMUNOLOGY
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
- (2010) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Anti-IL-6 receptor antibody suppressed T cell activation by inhibiting IL-2 production and inducing regulatory T cells
- (2010) Hiroto Yoshida et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- IL-6: from its discovery to clinical applications
- (2010) T. Kishimoto INTERNATIONAL IMMUNOLOGY
- A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis
- (2010) Mario H Cardiel et al. ARTHRITIS RESEARCH & THERAPY
- Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials
- (2009) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
- (2009) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- B-cell-directed therapies for autoimmune disease
- (2009) Thomas Dörner et al. Nature Reviews Rheumatology
- Lessons from animal models of arthritis over the past decade
- (2009) Wim Berg ARTHRITIS RESEARCH & THERAPY
- CTLA-4 directly inhibits osteoclast formation
- (2008) R Axmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
- (2008) E Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
- (2008) Edward Keystone et al. ARTHRITIS AND RHEUMATISM
- Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
- (2008) Paul Emery et al. LANCET
- The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
- (2008) Josef S Smolen et al. ARTHRITIS RESEARCH & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started